Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01586000 · ClinicalTrials.gov registry record · Phase 2
A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women
A Phase 2 study of Suppression of Ovulation, sponsored by Kimberly Myer.
- Completed
- Registry status
- Phase 2
- Development phase
- 197
- Enrollment target
- 8
- Study locations
NCT01586000: Completed Phase 2 study of Suppression of Ovulation, sponsored by Kimberly Myer.
NCT01586000 is a Phase 2 study of Suppression of Ovulation that has completed, run by Kimberly Myer. The registered enrollment target is 197 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (48% higher). The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01586000, a Phase 2 study of Suppression of Ovulation, has completed, sponsored by Kimberly Myer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 197 participants
- Enrollment target
- 8
- Study locations
Study Summary
This clinical trial is an experimental research study using a potential new form of birth control. Clinical trials include people who volunteer to take part in a study. Take your time to decide if you want to be part of this experimental research study. If you want to know more about this study first, ask the study doctor or study site staff. The investigators can also give you the study information written for doctors and clinic staff.
Primary Outcome
The primary outcome will be the number of days that bleeding or spotting is reported in the first 3 cycles (90 days) of treatment.
Conditions Studied
Interventions
- DRUG 10 µg/day E2 with NES 200® µg/day
- DRUG 20 µg/day E2 with NES 200® µg/day
- DRUG 40 µg/day E2 with NES 200® µg/day
Study Locations (8)
New York
- NYU School of Medicine - New York
- Columbia University - New York
Pennsylvania
- University of Pennsylvania School of Medicine - Philadelphia
- Univeristy of Pittsburgh School of Medicine - Pittsburgh
Maryland
- Johns Hopkins School of Medicine - Baltimore
Ohio
- University of Cincinnati - Cincinnati
Oregon
- Oregon Health & Science University - Portland
Virginia
- Eastern Virginia Medical School - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-05 |
| Phase | Phase 2 |
What the finished NCT01586000 record still lists
NCT01586000 is an interventional study that assigns participants to a tested intervention. The registered 197 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (48% higher).
The record links to 1 condition, with Suppression of Ovulation appearing as the primary indexed condition, and to 3 interventions - of which 10 µg/day E2 with NES 200® µg/day is the first listed.
NCT01586000 lists 8 locations in 6 states (New York, Pennsylvania, Maryland).
Frequently Asked Questions
What is clinical trial NCT01586000 about?
NCT01586000 is a clinical study titled "A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women". This clinical trial is an experimental research study using a potential new form of birth control. Clinical trials include people who volunteer to take part in a study. Take your time to decide if you want to be part of this experimental research study. If you want to know more about this study firs...
What is the current status of trial NCT01586000?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 197 participants. The study started on 2012-03. Estimated completion is 2015-05.
What conditions does trial NCT01586000 study?
This clinical trial studies the following conditions: Suppression of Ovulation.
What interventions are being tested in trial NCT01586000?
The interventions under investigation include: 10 µg/day E2 with NES 200® µg/day (DRUG), 20 µg/day E2 with NES 200® µg/day (DRUG), 40 µg/day E2 with NES 200® µg/day (DRUG).
Who is sponsoring clinical trial NCT01586000?
This trial is sponsored by Kimberly Myer, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01586000 being conducted?
This trial has 8 study locations across Maryland, New York, Ohio, Oregon, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01586000's enrollment target sits among peer trials
197 349th of 2000 higher than 1,652 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04219254 · 197 participants · Phase 1
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
- NCT06173778 · 197 participants · Phase 2
Semaglutide for Post-Smoking Cessation Weight Management
- NCT05203328 · 198 participants · NA
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
- NCT05426967 · 198 participants · NA
rTMS for Military TBI-related Depression
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia